EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Capital Work in Progress History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹21 Cr | ₹21 Cr | ₹19 Cr | ₹9.49 Cr | ₹8.03 Cr |
What is the latest Capital Work in Progress ratio of EVEREST ORGANICS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹21 Cr |
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹9.49 Cr |
| Mar2022 | ₹8.03 Cr |
How is Capital Work in Progress of EVEREST ORGANICS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹21 Cr | -3.20 | |
| Mar2025 | ₹21 Cr | 10.46 | |
| Mar2024 | ₹19 Cr | 103.86 | |
| Mar2023 | ₹9.49 Cr | 18.18 | |
| Mar2022 | ₹8.03 Cr | - | |
Compare Capital Work in Progress of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹219.5 Cr | -12.9% | -5.2% | -44.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -12.9% |
-5.2% |
-44.8% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses